Pre-Conference Workshop – Monday, January 27th, 2020
3:00pm
WORKSHOP: Oral Controlled Release Solid Dosage Forms

Tony Listro
Vice President, Technical Business Development
5:30pm
8:45am
Collaboration is King! Ice Breaker
8:55am

Rakesh Dixit, PhD
President & Chief Executive Officer
9:00am
Assessing the Advantages and Limitations of Supersaturation Based Formulations to Enable the Oral Drug Development of Poorly Soluble Drug Candidates

John Morrison, PhD
Senior Research Investigator, Discovery Pharmaceutics
9:35am
Structure-guided Selection of Solid Forms to Drive Oral Bioavailability of Protease Inhibitors

Phillip Snyder, PhD
Associate Director, Preclinical and Pharmaceutical Sciences
Vertex Pharmaceuticals
Maximizing Exposure for New Oral Compounds in Early Formulation Development

Ildiko Terebesi, PhD
Head, Early Formulation Development
Nanomedicines: Innovations in Bioavailability Enhancement & Delivery of Anti-Cancer Biologics

Rakesh Dixit, PhD
President & Chief Executive Officer
PANEL DISCUSSION: Bridging the Gap - Strategies for the Rapid Transition from Development to Commercial Manufacturing

Rakesh Dixit, PhD
President & Chief Executive Officer

Douglas Nesta, PhD
Senior Director, Biopharmaceutical Product Sciences

Rick Panicucci, PhD
Senior Vice President, CMC
QED Therapeutics

John Morrison, PhD
Senior Research Investigator, Discovery Pharmaceutics

Celal Albayrak, PhD
Chief Executive Officer & Co-Founder
1:40pm
Improving Product Bioavailability via Prodrug Approach
- Intrinsic solubility improvement by prodrug
- Permeability enhancement-Permeability enhancer vs. prodrug
- Improving drug delivery via metabolism of the prodrug
- Passive targeting delivery of nanoparticles via the enhanced permeability and retention (EPR)

Dedong Wu, PhD
Senior Scientist, Pharmaceutical Science
2:10pm
Food Effect Projections via Physiologically Based Absorption Modeling for Orally-dosed Drug Products

Binfeng Xia, PhD
Senior Manager, Pharmacokinetics, Dynamics, and Metabolism
Sanofi
2:40pm
Advances in Bioavailability Enhancement Strategies for Parenterals and Macromolecules

Douglas Nesta, PhD
Senior Director, Biopharmaceutical Product Sciences
3:10pm
The BioDuro Solution Engine: Solubility Enhancement Screening for Formulation Development

Ruchit Trivedi, PhD
Associate Director of Pharmaceutics
BioDuro
3:40pm
Afternoon Networking & Refreshment Break in Exhibit Hall
4:10pm
Use of Imaging to Assess Drug Delivery via Targeted Biologics

Andy Boswell, PhD
Senior Scientist
4:45pm
Prediction of Clinical Pharmacokinetics via Biopharmaceutics M&S: Case Studies on Amorphous Solid Dispersion and Long-Acting Implant Formulations

Wei Zhu, PhD
Associate Principal Scientist, Biopharmaceutics and Specialty Dosage Forms
Merck & Co.
5:20pm-
6:45pm
8:00am
9:00am
Redispersibility of Nanosolids: Challenges and Opportunities

Dina Zhang, PhD
Director, Pharmaceutical Sciences
Merck & Co.
Increasing Bioavailability of Solid Oral Dosage with an Integrated Development and Manufacturing Approach

Bei Chen, PhD
Principal Research Engineer, Operations Science & Technology
Evaluating the Utility of Gastrointestinal Systems in predicting Drug Performance: Focus on Tiny-TIM

Karthik Nagapudi, PhD
Senior Principal Scientist
11:00am
Morning Networking & Refreshment Break
11:30am
Enhancing Small Molecule Oral Bioavailability via Amorphous Nanoparticle Engineering

Kurt Ristroph, PhD
NSF Graduate Research Fellow
12:05pm
Computer-Aided Formulation Development for Small-Molecule Drugs and Biologics

John Shelley, PhD
Schrodinger Fellow
Networking Lunch
Advances 3D Printing in Pharmaceutical Manufacturing for Biopharmaceuticals

Joseph Della Rocca, PhD
Senior Scientist
Impact of Enabling Drug Delivery Approaches on PK performances
- Importance of Enabling Drug Delivery Approaches for different therapeutic areas
- Drug Product Design and Development strategy to achieve desired PK performances
- Case studies on Melt extrusion, Nanoparticles and Transdermal Drug Delivery systems
- Impact of Life Cycle Management on Drug Delivery approaches

Indrajit Ghosh, PhD
Senior Principal Scientist, Pharmaceutical Science and Technology
Celgene
Afternoon Networking & Refreshment Break
Small Molecule Oral Bioavailability Enhancement via Stability and Formulation Design

Celal Albayrak, PhD
Chief Executive Officer & Co-Founder
4:05pm
PBPM Applications in Drug Development and Dissolution Specification

Wen Lin, PhD
Senior Research Investigator
Novartis
4:40pm
Attend
Attend and walk away with 2 YEARS worth of new product development strategies, formulation approaches, delivery technologies and regulatory updates while decreasing drug product time-to-market in just 2 days!
WANT TO ATTEND BUT NEED HELP CONVINCING YOUR BOSS?
Let us help by generating you a custom message for you to send to your boss. Email it, talk them through it in person, tweet it to them 280 characters at a time: up to you.
We’re committed to your privacy. Curtis & Coulter uses the information you provide to us to contact you about upcoming and future events. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.